We are live on
!
Find out more
MC
Mayo Clinic Portfolio holdings
AUM
$2.9M
1-Year Est. Return
14.49%
This Fund
S&P 500
This Quarter
Est. Return
+6.42%
1 Year Est. Return
+14.49%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.2M
AUM Growth
-$35.7M
(-69%)
Cap. Flow
-$37.4M
Cap. Flow
% of AUM
-231.14%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
–
Reduced
1
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Immunome
IMNM
|
+$902K |
| 2 |
ImmunityBio
IBRX
|
+$4.4K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$34.9M |
| 2 |
Black Stone Minerals
BSM
|
+$2.86M |
| 3 |
MIRO
Miromatrix Medical Inc. Common Stock
MIRO
|
+$251K |
| 4 |
ClearPoint Neuro
CLPT
|
+$191K |
| 5 |
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
|
+$88.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 71.49% |
| 2 | Healthcare | 28.51% |
| 3 | Energy | 0% |
Similar funds
SWS
PWA
CU
QC
SOA
HVM
JC
MIG
Mayo Clinic's Q4 2023 Portfolio in Review
As of Q4 2023, Mayo Clinic held 11 positions worth $16.2M, down 69% from $51.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Mayo Clinic withdrew a net $37.4M in Q4 2023, closing 4 positions and reducing 1 holding. Its most notable exit was Black Stone Minerals, an estimated $2.86M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, down from 85% a quarter earlier, followed by Healthcare and Energy.
Against the trend, Mayo Clinic opened a new position in Immunome worth $1.16M.
- Mayo Clinic's largest Q4 2023 buy was Immunome: 108,480 shares worth $1.16M.
- Mayo Clinic's biggest Q4 2023 reduction was iShares MSCI ACWI ETF, cutting an estimated $34.9M.
- Mayo Clinic fully exited Black Stone Minerals in Q4 2023, selling an estimated $2.86M.
- Mayo Clinic's ten largest holdings make up 100% of its $16.2M portfolio in Q4 2023.
- Mayo Clinic opened 2 new positions and closed 4 in Q4 2023.
- Mayo Clinic's portfolio value fell 69% quarter-over-quarter to $16.2M.
Based on Mayo Clinic's 13F filing for Q4 2023, filed 13 Feb 2024.